Purpose: The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical examiners and coroners, forensic and clinical laboratory personnel, and all other related communities about new information surrounding the emergent synthetic opioid protonitazene.
Tags: New Drug Trends Opioid Crisis Protonitazene Safety AlertNew Synthetic Opioid Protonitazene Increasing in Prevalence as “Nitazenes” Gain Traction Across the United States and Canada
-
Protenus Drug Diversion Digest: Year in Review 2017
Charlie Cichon / / / Research & Publications
We’re very excited to announce the release of the Protenus Diversion Digest, a first-of-its-kind piece of analysis – developed by Protenus’...
-
Metonitazene Begins Proliferation as Newest Synthetic Opioid Among Latest Cycle of Non-Fentanyl Related Drugs
Lisa McElhaney / / / Research & Publications
CSFRE – Public Alert Metonitazene is a potent synthetic opioid bearing structural resemblance to etonitazene, a synthetic opioid that...
-
Pill Press Laws: A Forgotten Aspect of Counterfeit Drug-Making (LAPPA)
Lisa McElhaney / / / Research & Publications
Legislative Analysis and Public Policy Association – Because of fentanyl’s wide availability, low cost, and high potency, counterfeit pill...
-
Illegal Pill Presses: An Overlooked Threat to American Patients – 2021 Update
Lisa McElhaney / / / Research & Publications
Illegal Pill Presses Pose Serious, Nationwide Threat To American Patients And Communities Continued research by the Partnership for Safe...
-
WV: Announcement of Newly Identified Novel Psychoactive Substance (NPS) in the United States.
Lisa McElhaney / / / Research & Publications
N-Pyrrolidino Etonitazene has been identified in one case in May 2021. The geographical and demographical breakdown is below: Geographical...
-
2021 European Drug Report – Trends and Developments (EMCDDA)
Lisa McElhaney / / / Research & Publications
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) released its 2021 drug report this week. Using data...
-
New Benzodiazepines in Europe – a Review
Lisa McElhaney / / / Research & Publications
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) released an update on benzodiazepines this week. As of February...
-
NFLIS – 2020 Annual Report – Utilizing DEA Synth-Opioids
Lisa McElhaney / / / Research & Publications
The Drug Enforcement Administration’s (DEA’s) Real-Time Communication Synth-Opioids Network (Synth-Opioids) is designed to create opportunities for swift information exchange...
Membership Account
Latest NADDI News
-
NY: NYS DoH Issues Warning that Synthetic Cannabinoids Sold in the Mohawk Valley Contain Laboratory Confirmed Synthetic Opioids that Can Create a Deadly Cocktail September 19, 2023
-
NY: Two Charged with Federal Narcotics Offenses Resulting in Death in Connection with the Poisoning of Four Children at a New York Daycare September 19, 2023
-
MA: Illegal Kickbacks in Sober Home Operations: The Dark Side of Substance Abuse Recovery September 18, 2023